Expression of c-erbb-2 oncoprotein: A prognostic indicator in human breast cancer

Cancer Research

Volumn 49, Issue 8, 1989, Pages 2087-2090

  Wright, Christopher ^a   Angus, Brian ^a   Nicholson, Stewart ^a   Sainsbury, J Richard C ^a   Cairns, John ^a   Gullick, William J ^b   Kelly, Peter ^a   Harris, Adrian L ^a   Wilson Horne, C H ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; FEMALE; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN;

EID: 0024592905     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schechter, A. L., Stern, D. F., Vaidyanathan, L., et al. The neu oncogene: An erbB-related gene encoding a 185,000-M, tumor antigen. Nature (Lond.), 312:513-516, 1984.
2. Coussens, L., Yang-Feng, T. L., Liao, Y.-C., et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neuoncogene. Science (Wash. DC), 230: 1132-1139, 1985.
3. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science (Wash. DC), 232: 1644-1646, 1986.
4. Yamamoto, T., Ikawa, S., Akiyama, T., et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature (Lond.), 319: 230-234, 1986.
5. Schechter, A. L., Hung, M.-C., Vaidyanathan, L., et al. The neu gene: An erbB-homologousgene distinct from and unlinked to the gene encoding the EGF receptor. Science (Wash. DC), 229:976-978, 1985.
6. Semba, K., Ramata, N., Toyoshima, K., and Yamamoto, T. A v-erbB related proto-oncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA, 82: 6497-6501, 1985.
7. King, C. R., Kraus, M. H., and Aaronson, S. A. Amplification of a novel verbB-relatedgene in a human mammary carcinoma. Science (Wash. DC), 229: 974-976, 1985.
8. Yokota, J., Yamamoto, T., Toyoshima, K., et al. Amplificai imi of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, 1: 765-766, 1986.
9. Tal, M., Wetzler, M., Josefberg, Z., et al. Sporadic amplification of the HER2/neu proto-oncogene in adenocarcinomas of various tissues. Cancer Res., 48: 1517-1520, 1988.
10. Venter, D. J., Tuzi, N. L., Kumar, S., and Gullick, W. J. Over expression of the c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification. Lancet, 2:69-72, 1987.
11. Berger, M. S., Locher, G. W., Saurer, S., et al. Correlation ofc-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48: 1238-1243, 1988.
12. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Wash. DC), 235: 177-182, 1987.
13. Sainsbury, J. R. C., Farndon, J. R., Needham, G. K., Malcolm, A. J., and Harris, A. L. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, 1: 1398-1402, 1987.
14. Kadowaki, T., Kasuga, M., Tobe, K., et al. AM, 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor receptor stimulated KB cells is the product ofc-erbB-2 gene. Biochem. Biophys. Res. Commun., 144:699-704, 1987.
15. Akiyama, T., Saito, T., Ogawara, H., Toyoshima, K., and Yamamoto, T. Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells. Mol. Cell Biol., 8: 1619-1626, 1988.
16. Nicholson, S., Sainsbury, J. R. C., Needham, G. K., Chambers, P., Farndon, J. R., and Harris, A. L. Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut-off points of clinical relevance. Int. J. Cancer, 42:36-41, 1988.
17. Hawkins, R. A., Hall, A., and Freedman, B. A simple method for determination of estrogen receptor concentrations in breast tumours and other tissues. Clin. Chim. Acta, 64: 203-210, 1975.
18. Gullick, W. J., Berger, M. S., Bennett, P. L. P., Rothbard, J. B., and Waterfield, M. D. Expression of the c-erbB-2 protein in normal and transformed cells. Int. J. Cancer, 40: 246-254, 1987.
19. Elston, C. W., Gresham, G. A., Rao, G. S., et al. The Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer: Clinicopathological aspects. Br. J. Cancer, 45: 655-669, 1982.
20. Howat, J. M. T., Harris, M., Swindell, R., and Barnes, D. M. The effect of estrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br. J. Cancer, 51: 263-270, 1985.
21. Hahnel, R., Woodings, T., and Vivian, A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer (Phila.), 44:671, 1979.
22. Stewart, J. F., Rubens, R. D., Millis, R. R., King, R. J. B., and Hayward, J. L. Steroid receptors and prognosis in operable (Stage I and II) breast cancer. Eur. J. Cancer Oncol., 19: 1381, 1983.
23. Peto, R., Pike, M. C., Armitage, P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer, 35:1-39, 1977.
24. Cox, D. R. Regression models and life tables. J. R. Stai. Soc. B., 34: 187-202, 1972.
25. Dixon, W. J. BMDP Statistical Software. Berkeley, CA: University of California Press, 1985.
26. Van de Vijver, M., Van de Bersselaar, R., Devilee, P., Corenelisse, C., Peterse, J., and Nusse, R. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell Biol., 7: 2019-2023, 1987.
27. Machin, L. G., Gullick, W. J., Gibbs, N. M., Powles, T. J., Harrison, S., and Gusterson, B. A. Immunohistochemical localization of c-erbB-2 immunoreactivity in benign and malignant breast disease. J. Pathol., 154:43A, 1988.
28. Diebin, J. A., Link, V. C., Weinberg, R. A., and Greene, M. I. Inhibition of tumour growth by a monoclonal antibody reactive with an oncogene-encoded tumour antigen. Proc. Natl. Acad. Sci. USA, 83: 9129-9133, 1986.
29. Van de Vijver, M. J., Peterse, J. L., Mooi, W. J., et al. Neu protein overexpression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in Stage II breast cancer. N. Engl. J. Med., 319: 1239-1245, 1988.